3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
3
Venous Thrombosis
2
Thromboembolism
2
Ovarian Neoplasms
2
Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Thrombosis
1
Sarcoma
1
Pulmonary Embolism
1
Postoperative Complications
1
Lung Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Dalteparin
10
apixaban
9
Tinzaparin
4
Enoxaparin
4
Heparin, Low-Molecular-Weight
3
edoxaban
2
abelacimab
2
Rivaroxaban
2
MAA868
2
Dabigatran
2
perflutren
1
isoquercitrin
1
enoxaparin sodium
1
bemiparin
1
Warfarin
1
Sulfur Hexafluoride
1
Rosuvastatin Calcium
1
Hospitals
1
Fondaparinux
1
Fluorodeoxyglucose F18
1
Educational Status
1
Deoxyribonucleases
1
Acetylcysteine
1
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pulmonary Embolism
×
Fondaparinux
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts